Follow the Onconetix, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3m. The latest transaction was disclosed on 22 April 2026 (Cession). Among the most active insiders: HRT FINANCIAL LP. The full history is accessible without an account.
22
Insider Decl.
n/a
Thresholds
€129,543
3 ops.
Buy Volume
€122,698
3 ops.
Sell Volume
32Σ signal
Buys €129,543€122,698 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Onconetix, Inc. es una empresa que cotiza en el mercado XNAS, especializada en el desarrollo de soluciones innovadoras para el diagnóstico del cáncer. Se centra en la mejora de los métodos de detección temprana de enfermedades oncológicas.